About

Cory Berkland, PhD, is the Solon E Summerfield Distinguished Professor at the University of Kansas, US. He is a co-founder and was Chief Scientific Officer of Orbis Biosciences (now Adare Pharmaceuticals) amongst other companies including Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Professor Berkland has a PhD in Chemical and Biomolecular Engineering from the University of Illinois, Urbana-Champaign, where he co-invented and developed Orbis’s technology.

Contributions

GI/ORAL

SINGLE-STEP FUNCTIONAL COATINGS FOR INCREASED EFFICIENCIES

In this article about oral drug innovation, Cory Berkland and Nathan Dormer focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.

More contributions

GI/ORAL

THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION

Cory Berkland and Nathan Dormer look at what controlled-release powder delivery systems can offer, noting that a rising number of pharmaceutical companies and manufacturing organisations are incorporating controlled-release powder manufacturing to their portfolios.